英文名稱
1-{[2-Fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
純度
>95% (HPLC)
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione is an intermediate in the synthesis of Elagolix, a gonadotropin-releasing hormone antagonist (GnRH) used in the treatment of endometriosis.